As the landscape of 340B program compliance continues to evolve, staying ahead of reimbursement challenges and legislative shifts is crucial…
Menu
As the landscape of 340B program compliance continues to evolve, staying ahead of reimbursement challenges and legislative shifts is crucial…
The 340B Drug Pricing Program, while enabling eligible healthcare organizations to purchase medications at significantly reduced prices, has faced ongoing…
In this white paper, we’ll explore how Pharmacy Benefit Managers (PBMs) can leverage flexibility, innovation, and strategic partnerships to transform…
The Pharmacy Benefit Management (PBM) industry is on a trajectory of remarkable growth, with projections indicating global revenues will reach…
Maintaining a successful 340B program demands attentiveness and continued optimization. In this white paper, Draffin Tucker’s Brittany Edwards delves into…
In this white paper, 340B industry expert, Jason Prokopik of Blue & Co., provides a comprehensive exploration of the complexities inherent…
Interested in a deeper understanding of NADAC pricing as it relates to the drug pricing landscape? This paper provides a…
Kristin Fox-Smith, Managing Director Visante The 340B Drug Pricing Program has been instrumental in ensuring affordable prescription medications for healthcare…
McKaylin Felton, ACI 340B Account Management During the COVID-19 pandemic, the 340B program witnessed a significant shift in auditing practices.…
340B ESP: THE BASICS What is 340B ESP? 340B ESP, also known as Second Sight, allows manufacturers and 340B covered…
With new contract pharmacy restrictions recently announced, and more expected to come in the near future, ensuring compliance is more…
Part 7 of the 340B Webinar Series – 340B Advanced Reporting, Larry Crowder, VP of 340B Solutions at Cervey talks with Ambre Ayoub, 340B…
410 Kay Lane
Shreveport, LA 71115
1-800-710-9348
